Hinova Pharmaceuticals, Inc. engages in the research and development of pharmaceutical products. It offers castration-resistant prostate cancer treatment and anti-gout and hyperuricemia drugs. The company was founded by Yuan Wei Chen and Xing Hai Li on February 5, 2013 and is headquartered in Chengdu, China.